DE1670007A1 - N-(tert.-Aminoalkyl)-amidderivate und Verfahren zu ihrer Herstellung - Google Patents

N-(tert.-Aminoalkyl)-amidderivate und Verfahren zu ihrer Herstellung

Info

Publication number
DE1670007A1
DE1670007A1 DE19671670007 DE1670007A DE1670007A1 DE 1670007 A1 DE1670007 A1 DE 1670007A1 DE 19671670007 DE19671670007 DE 19671670007 DE 1670007 A DE1670007 A DE 1670007A DE 1670007 A1 DE1670007 A1 DE 1670007A1
Authority
DE
Germany
Prior art keywords
compound
formula
product
aryl
acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19671670007
Other languages
German (de)
English (en)
Inventor
Wright Jun William Blythe
Brabander Herbert Joseph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DE1670007A1 publication Critical patent/DE1670007A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19671670007 1966-11-25 1967-11-23 N-(tert.-Aminoalkyl)-amidderivate und Verfahren zu ihrer Herstellung Pending DE1670007A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59683166A 1966-11-25 1966-11-25
US59681066A 1966-11-25 1966-11-25

Publications (1)

Publication Number Publication Date
DE1670007A1 true DE1670007A1 (de) 1971-01-21

Family

ID=27082649

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19671670007 Pending DE1670007A1 (de) 1966-11-25 1967-11-23 N-(tert.-Aminoalkyl)-amidderivate und Verfahren zu ihrer Herstellung

Country Status (9)

Country Link
BE (1) BE707032A (es)
CH (1) CH509311A (es)
DE (1) DE1670007A1 (es)
DK (1) DK127979B (es)
ES (1) ES347622A1 (es)
FR (1) FR7590M (es)
GB (1) GB1166364A (es)
IL (1) IL28799A (es)
NL (1) NL6715434A (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1009846B (de) * 1954-03-27 1957-06-06 Strautmann & Soehne O H G B Musmuehle
EP0361961A1 (en) * 1988-09-30 1990-04-04 Lilly S.A. Organic componds and their use as pharmaceuticals
EP0368464B1 (en) * 1988-09-30 1994-02-02 Lilly S.A. Thiopene-2 carboxamide derivatives and their pharmaceutical use

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0034481B1 (en) * 1980-02-14 1984-05-30 Grigg, Ronald Ernest 2-methyl-5-thiazole-methylamine and carboxamide derivatives
NL8005133A (nl) * 1980-09-12 1982-04-01 Duphar Int Res Fenylpiperazinederivaten met antiagressieve werking.
US5166157A (en) * 1989-12-20 1992-11-24 Adir Et Compagnie Naphthyl piperazines useful as 5-HT1A receptor ligands
US5661163A (en) * 1995-06-07 1997-08-26 Merck & Co., Inc. Alpha-1a adrenergic receptor antagonists

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1009846B (de) * 1954-03-27 1957-06-06 Strautmann & Soehne O H G B Musmuehle
EP0361961A1 (en) * 1988-09-30 1990-04-04 Lilly S.A. Organic componds and their use as pharmaceuticals
EP0368464B1 (en) * 1988-09-30 1994-02-02 Lilly S.A. Thiopene-2 carboxamide derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
IL28799A (en) 1972-07-26
GB1166364A (en) 1969-10-08
ES347622A1 (es) 1969-06-01
CH509311A (de) 1971-06-30
DK127979B (da) 1974-02-11
NL6715434A (es) 1968-05-27
BE707032A (es) 1968-05-24
FR7590M (es) 1970-01-12

Similar Documents

Publication Publication Date Title
DE3005948C2 (es)
DE2461596A1 (de) 8-hydroxycarbostyril-derivate, verfahren zu ihrer herstellung und arzneimittel
DE3026201A1 (de) Aminoaetheroxide, verfahren zu ihrer herstellung sowie ihre therapeutische verwendung
EP0006506A1 (de) 1,2-Dihydro-chinolin-2-on-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
DE2461604A1 (de) 8-hydroxy-3,4-dihydrocarbostyril- derivate, verfahren zu ihrer herstellung und arzneimittel
DE2461595A1 (de) Carbostyril- und 3,4-dihydrocarbostyril-derivate, verfahren zu ihrer herstellung und arzneimittel
DE1670007A1 (de) N-(tert.-Aminoalkyl)-amidderivate und Verfahren zu ihrer Herstellung
DE2426149C3 (de) 7-Fluor-substituierte Phenothiazine, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel
DE2431609C2 (de) Sulfamoylbenzoesäureamid-Derivate, Verfahren zu deren Herstellung und pharmazeutische Präparate
DE3025238C2 (es)
CH623307A5 (es)
DE2628464C2 (de) Xanthen-9-carbonsäureester, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende pharmazeutische Mittel
DE1289845B (de) 4-(4'-Hydroxy-4'-phenylpiperidino)-butyrophenone, deren Saeureadditionssalze sowie Verfahren zu deren Herstellung
CH653336A5 (de) Kondensierte as-triazin-derivate.
DE2330124A1 (de) Anilidderivate, ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE1090667B (de) Verfahren zur Herstellung von basischen Phenthiazinderivaten
CH659063A5 (de) Verfahren zur herstellung von basischen oximaethern.
DE1620128C3 (de) N Aminoalkyl 2 phenoxy 2 phenyl acetamide, deren Saureadditionssalze, sowie Verfahren zu ihrer Herstellung
AT276372B (de) Verfahren zur Herstellung von neuen N-(tert.-Aminoalkyl)-amidderivaten und deren Säureadditionssalzen
DE2359359A1 (de) Fluor-substituierte thioxanthene und verfahren zu deren herstellung sowie diese enthaltende pharmazeutische mittel
DE1035150B (de) Verfahren zur Herstellung von N-monosubstituierten ª‡-(tert.-Aminoalkyl)-ª‡-phenyl-acetamiden
DE2745064A1 (de) Pyridinverbindungen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2551235B2 (de) Aryloxyalkylpiperidine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2807169A1 (de) Ein neues pyridyl-piperazinderivat und verfahren zu seiner herstellung
DE825840C (de) Verfahren zur Herstellung substituierter Piperazine